Depressive symptoms post hip fracture in older adults are associated with phenotypic and functional alterations in T cells

Immunity and Ageing

Volumn 11, Issue 1, 2014, Pages

  Duggal, Niharika Arora ^a   Upton, Jane ^a   Phillips, Anna C ^a   Hampson, Peter ^a   Lord, Janet M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Ageing; Cortisol; Depressive symptoms; Hip fracture; Immunity; Inflammation; Stress; T cell

Indexed keywords

CD28 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; HLA DR ANTIGEN; HYDROCORTISONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; AGED; AGING; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; FEMALE; GERIATRIC DEPRESSION SCALE; HIP FRACTURE; HUMAN; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MENTAL STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; SENESCENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 84924857969     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/s12979-014-0025-5     Document Type: Article

References (72)

1. Dicarlo AL, Fuldner R, Kaminski J, Hodes R: Aging in the context of immunological architecture, function and disease outcomes. Trends Immunol 2009, 30(7):293-294.
2. Steinmann GG, Klaus B, Muller-Hermelink HK: The involution of the ageing human thymic epithelium is independent of puberty. A Morphometric Study Scand J Immunol 1985, 22(5):563-575.
3. Pawelec G, Larbi A, Derhovanessian E: Senescence of the human immune system. J Comp Pathol 2010, 142(Suppl 1):S39-S44.
4. Utsuyama M, Hirokawa K, Kurashima C, Fukayama M, Inamatsu T, Suzuki K, Hashimoto W, Sato K: Differential age-change in the numbers of CD4 + CD45RA+ and CD4 + CD29+ T cell subsets in human peripheral blood. ech Ageing Dev 1992, 63(1):57-68.
5. De Paoli P, Battistin S, Santini GF: Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population. Clin Immunol Immunopathol 1988, 48(3):290-296.
6. Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Müller CA, Pircher H, Pawelec G: Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol 2003, 38(8):911-920.
7. Kudlacek S, Jahandideh-Kazempour S, Graninger W, Willvonseder R, Pietschmann P: Differential expression of various T cell surface markers in young and elderly subjects. Immunobiology 1995, 192(3-4):198-204.
8. Vallejo AN: CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005, 205:158-169.
9. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ: T cell subset-specific susceptibility to aging. Clin Immunol 2008, 127(1):107-118.
10. Haynes L, Eaton SM: The effect of age on the cognate function of CD4+ T cells. Immunol Rev 2005, 205:220-228.
11. Sandmand M, Bruunsgaard H, Kemp K, Andersen-Ranberg K, Pedersen AN, Skinhøj P, Pedersen BK. Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?
12. Sindermann J, Kruse A, Frercks HJ, Schütz RM, Kirchner H: Investigations of the lymphokine system in elderly individuals. Mech Ageing Dev 1993, 70(1-2):149-159.
13. McNerlan SE, Rea IM, Alexander HD: A whole blood method for measurement of intracellular TNF-alpha, IFN-gamma and IL-2 expression in stimulated CD3+ lymphocytes: differences between young and elderly subjects. Exp Gerontol 2002, 37(2-3):227-234.
14. Luz C, Dornelles F, Preissler T, Collaziol D, da Cruz IM, Bauer ME: Impact of psychological and endocrine factors on cytokine production of healthy elderly people. Mech Ageing Dev 2003, 124(8-9):887-895.
15. Segerstrom SC, Miller GE: Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004, 130(4):601-630.
16. Hawkley LC, Cacioppo JT: Stress and the aging immune system. Brain Behav Immun 2004, 18(2):114-119.
17. Butcher SK, Killampalli V, Chahal H, Kaya Alpar E, Lord JM: Effect of age on susceptibility to post-traumatic infection in the elderly. Biochem Soc Trans 2003, 31(2):449-451.
18. Khanfer R, Lord JM, Phillips AC: Neutrophil function and cortisol:DHEAS ratio in bereaved older adults. Brain Behav Immun 2011, 25(6):1182-1186.
19. Koval KJ, Zuckerman JD: Functional recovery after fracture of the hip. The Journal of bone and joint surgery. J Bone Joint Surg Am 1994, 76(5):751-758.
20. Johnell O, Gullberg B, Allander E, Kanis JA: The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int 1992, 2(6):298-302.
21. Cole MG, Dendukuri N: Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003, 160(6):1147-1156.
22. Holmes JD, House AO: Psychiatric illness in hip fracture. Age Ageing 2000, 29(6):537-546.
23. Nightingale S, Holmes J, Mason J, House A: Psychiatric illness and mortality after hip fracture. Lancet 2001, 357(9264):1264-1265.
24. Mossey JM, Knott K, Craik R: The effects of persistent depressive symptoms on hip fracture recovery. J Gerontol 1990, 45(5):M163-M168.
25. Tsigos C, Chrousos GP: Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosomatic Res 2002, 53(4):865-871.
26. Hazeldine J, Arlt W, Lord JM: Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol 2010, 120(2-3):127-136.
27. Aguilera G: HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol 2011, 46(2-3):90-95.
28. Vermeulen A: Dehydroepiandrosterone sulfate and aging. Ann N Y Acad Sci 1995, 774:121-127.
29. Buford TW, Willoughby DS: Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Appl Physiol Nutr Metab 2008, 33(3):429-433.
30. Butcher SK, Killampalli V, Lascelles D, Wang K, Alpar EK, Lord JM: Raised cortisol:DHEAS ratios in the elderly after injury: potential impact upon neutrophil function and immunity. Aging Cell 2005, 4(6):319-24.
31. Duggal NA, Upton J, Phillips AC, Hampson P, Lord JM: Depressive symptoms are associated with reduced neutrophil function in hip fracture patients. Brain Behav Immun 2013, 33:173-182.
32. Geginat J, Sallusto F, Lanzavecchia A: Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 2001, 194(12):1711-1719.
33. Focosi D, Bestagno M, Burrone O, Petrini M: CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 2010, 87(1):107-16.
34. Voehringer D, Koschella M, Pircher H: Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 2002, 100(10):3698-3702.
35. Kamphorst AO, Ahmed R: Manipulating the PD-1 pathway to improve immunity. Curr Opin Immunol 2013, 25(3):381-388.
36. Wherry EJ: T cell exhaustion. Nat Immunol 2011, 12(6):492-499.
37. Channappanavar R, Twardy BS, Krishna P, Suvas S: Advancing age leads to predominance of inhibitory receptor expressing CD4 T cells. Mech Ageing Dev 2009, 130(10):709-12.
38. Shimada Y, Hayashi M, Nagasaka Y, Ohno-Iwashita Y, Inomata M: Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells. Exp Gerontol 2009, 44(8):517-522.
39. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B: Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370(9590):851-858.
40. Irwin MR, Miller AH: Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007, 21(4):374-383.
41. Schleifer SJ, Keller SE, Meyerson AT, Raskin MJ, Davis KL, Stein M: Lymphocyte function in major depressive disorder. Arch Gen Psychiatry 1984, 41(5):484-486.
42. Kronfol Z, House JD: Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatr Scand 1989, 80(2):142-147.
43. Charmandari E, Tsigos C, Chrousos G: Endocrinology of the stress response. Annu Rev Physiol 2005, 67:259-284.
44. Leonard BE, Myint A: The psychoneuroimmunology of depression. Hum Psychopharmacol 2009, 24(3):165-75.
45. Herold MJ, McPherson KG, Reichardt HM: Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006, 63(1):60-72.
46. Atanackovic D, Kröger H, Serke S, Deter HC: Immune parameters in patients with anxiety or depression during psychotherapy. Affect Disord 2004, 81(3):201-209.
47. Başterzi AD, Yazici K, Buturak V, Cimen B, Yazici A, Eskandari G, Tot Acar S, Taşdelen B: Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(1):70-75.
48. Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, de Jonckheere C, Minner B, Raus J: Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 1992, 22(1):45-53.
49. Maes M, Stevens W, DeClerck L, Bridts C, Peeters D, Schotte C, Cosyns P: Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand 1992, 86(6):423-431.
50. Amati M, Tomasetti M, Ciuccarelli M, Mariotti L, Tarquini LM, Bracci M, Baldassari M, Balducci C, Alleva R, Borghi B, Mocchegiani E, Copertaro A, Santarelli L: Relationship of job satisfaction, psychological distress and stress-related biological parameters among healthy nurses: a longitudinal study. J Occup Health 2010, 52(1):31-38.
51. Kern F, Ode-Hakim S, Vogt K, Hoflich C, Reinke P, Volk HD: The enigma of CD57 + CD28- T cell expansion-anergy or activation? Clin Exp Immunol 1996, 104(1):180-184.
52. Trzonkowski P, Mysliwska J, Godlewska B, Szmit E, Lukaszuk K, Wieckiewicz J, Brydak L, Machala M, Landowski J, Mysliwski A: Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav Immunity 2004, 18(2):135-48.
53. Effros RB: Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol 2011, 46(2-3):135-140.
54. Saurwein-Teissl M, Lung TL, Marx F, Gschösser C, Asch E, Blasko I, Parson W, Böck G, Schönitzer D, Trannoy E, Grubeck-Loebenstein B: Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002, 168(11):5893-5899.
55. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ: Down-regulation of CD28 expression by TNF-alpha. J Immunol 2001, 167(6):3231-3238.
56. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA: The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007, 81(14):7759-7765.
57. Morley JK, Batliwalla FM, Hingorani R, Gregersen PK: Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. J Immunol 1995, 154(11):6182-6190.
58. Maes M: Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(3):664-675.
59. Duggal NA, Beswetherick A, Upton J, Hampson P, Phillips AC, Lord JM: Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol 2014, 54:27-34.
60. Maes M, Stevens WJ, Declerck LS, Bridts CH, Peeters D, Schotte C, Cosyns P: Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry 1993, 17(2):241-255.
61. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15(3):199-226.
62. Pavón L, Sandoval-López G, Eugenia Hernández M, Loría F, Estrada I, Pérez M, Moreno J, Avila U, Leff P, Antón B, Heinze G: Th2 cytokine response in Major Depressive Disorder patients before treatment. J Neuroimmunol 2006, 172(1-2):156-165.
63. Ouyang X, Yang Z, Zhang R, Arnaboldi P, Lu G, Li Q, Wang W, Zhang B, Cui M, Zhang H, Liang-Chen J, Qin L, Zheng F, Huang B, Xiong H: Potentiation of Th17 cytokines in aging process contributes to the development of colitis. Cell Immunol 2011, 266(2):208-217.
64. Chen Y, Jiang T, Chen P, Ouyang J, Xu G, Zeng Z, Sun Y: Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells. Psychiatry Res 2011, 188(2):224-230.
65. Leonard BE: The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 2010, 6(3):205-212.
66. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL: A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67(5):446-457.
67. Maes M, Scharpé S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P: Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 1993, 49(1):11-27.
68. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000, 22(4):370-379.
69. Phillips AC, Upton J, Duggal NA, Carroll D, Lord JM: Depression following hip fracture is associated with increased physical frailty in older adults: the role of the cortisol: dehydroepiandrosterone sulphate ratio. BMC Geriatrics 2013, 13:60.
70. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-1983;17(1):37-49.1982. 17(1): p. 37-49.
71. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67(6):361-70.
72. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res 2002, 52(2):69-77.